1450 North Mcdowell Boulevard
Suite 150
Petaluma, CA 94954
United States
415 578 9583
https://retinalgenix.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Dr. Jerry Katzman | CEO, President & Chairman | N/D | N/D | 1953 |
Mr. Virender K. Ahluwalia | Interim Chief Financial Officer | N/D | N/D | 1958 |
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders. Its products include the RetinalGeniX, a resolution retinal imaging diabetic screening system that provides a 200-degree field of view without requiring pupil dilation; and RetinalCam, a real-time in-home retinal monitoring, imaging, and physician alert system. The company was incorporated in 2017 and is based in Petaluma, California. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
La calificación ISS Governance QuickScore de RetinalGenix Technologies Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.